| 1.21 0 (0%) | 08-28 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.98 | 1-year : | 4.15 |
| Resists | First : | 2.55 | Second : | 3.55 |
| Pivot price | 1.19  |
|||
| Supports | First : | 0.93 | Second : | 0.77 |
| MAs | MA(5) : | 1.19  |
MA(20) : | 1.64 |
| MA(100) : | 2.89 |
MA(250) : | 3.11 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 20.2 |
D(3) : | 14.1 |
| RSI | RSI(14): 30 |
|||
| 52-week | High : | 5.69 | Low : | 0.93 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ACH ] has closed below upper band by 44.0%. Bollinger Bands are 66.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.25 - 1.26 | 1.26 - 1.26 |
| Low: | 1.18 - 1.19 | 1.19 - 1.19 |
| Close: | 1.21 - 1.22 | 1.22 - 1.23 |
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
Fri, 28 Aug 2026
Enterprise value to revenue forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Fri, 28 Aug 2026
Connor Clark & Lunn Investment Management Ltd. Invests $4.41 Million in Accendra Health, Inc. $ACH - MarketBeat
Tue, 25 Aug 2026
2,536,699 Shares in Accendra Health, Inc. $ACH Purchased by Paradigm Capital Management Inc. NY - MarketBeat
Mon, 17 Aug 2026
Accendra Health Drops Equity Issuance Plan, Targets September CEO Announcement - citybiz
Mon, 17 Aug 2026
Accendra Health's $300M Revolving Credit Facility Was Undrawn—What's Next? - Stock Titan
Tue, 11 Aug 2026
Baird downgrades Accendra Health stock rating on weak results - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 77 (M) |
| Shares Float | 57 (M) |
| Held by Insiders | 7.6 (%) |
| Held by Institutions | 84.2 (%) |
| Shares Short | 5,330 (K) |
| Shares Short P.Month | 5,860 (K) |
| EPS | -1.46 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -7.16 |
| Profit Margin | -11.5 % |
| Operating Margin | -1.6 % |
| Return on Assets (ttm) | 0.6 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -10.2 % |
| Gross Profit (p.s.) | 15.47 |
| Sales Per Share | 34.46 |
| EBITDA (p.s.) | 3.74 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -180 (M) |
| Levered Free Cash Flow | 420 (M) |
| PE Ratio | -0.85 |
| PEG Ratio | 0.6 |
| Price to Book value | -0.18 |
| Price to Sales | 0.03 |
| Price to Cash Flow | -0.52 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|